![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Immunicon (MM) | NASDAQ:IMMC | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.19 | 0 | 01:00:00 |
FORM 3
|
Washington, D.C. 20549 |
OMB APPROVAL
OMB Number: 3235-0104 Expires: January 31, 2008 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person * Lipcsey Teresa |
2. Date of Event Requiring Statement (MM/DD/YYYY)
|
3. Issuer Name and Ticker or Trading Symbol IMMUNICON CORP [IMMC] |
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
_____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below) VP Finance & Controller / |
|
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Beneficially Owned |
|||
1.Title of Security
(Instr. 4) |
2. Amount of Securities Beneficially Owned
(Instr. 4) |
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) |
4. Nature of Indirect Beneficial Ownership
(Instr. 5) |
Common Stock | 18657 (1) | D |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||
1. Title of Derivate Security
(Instr. 4) |
2. Date Exercisable and Expiration Date
(MM/DD/YYYY) |
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) |
6. Nature of Indirect Beneficial Ownership
(Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Incentive Stock Option (right to buy) | 12/30/2004 (2) | 12/30/2013 | Common Stock | 43334 | $6 | D | |
Incentive Stock Option (right to buy) | 4/15/2005 (2) | 4/15/2014 | Common Stock | 200 | $8 | D | |
Incentive Stock Option (right to buy) | 1/28/2006 (2) | 1/28/2015 | Common Stock | 25000 | $6.12 | D | |
Incentive Stock Option (right to buy) | 12/26/2005 (2) | 8/26/2015 | Common Stock | 15000 | $4.13 | D | |
Incentive Stock Option (right to buy) | 9/19/2008 (3) | 9/19/2017 | Common Stock | 50000 | $0.95 | D |
Explanation of Responses: | |
( 1) | 5,443 of these shares were obtained via participation in the Immunicon ESPP during the period 04/17/2004 thru 10/15/2007. 13,214 shares were obtained from a grant of non-vested of shares on 01/24/2007. |
( 2) | These shares are fully vested and exercisable as of 03/14/2008. |
( 3) | This option vests annually in four (4) equal installments over four (4) years (25% per year) and expires ten (10) years from the date of grant. |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
Lipcsey Teresa
3401 MASONS MILL RD SUITE 100 HUNTINGDON VALLEY, PA 19006 |
|
|
VP Finance & Controller |
|
Signatures
|
||
Teresa O. Lipcsey | 3/27/2008 | |
** Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Immunicon Chart |
1 Month Immunicon Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions